•   
  • $0.00 USD
    0

About Horizon Discovery

Horizon Discovery  is a revenue-generating life science company supplying research tools to organisations engaged in genomics research and the development of personalised medicines. Horizon has a diverse and international customer base of circa 1,000 organisations across circa 50 countries, including major pharmaceutical, biotechnology and diagnostic companies as well as leading academic research centers. The Company supplies its products and services into multiple markets, estimated to total in excess of £29 billion in 2015.

Horizon's core capabilities are built around its proprietary translational genomics platform, a high-precision and flexible suite of gene editing tools able to alter almost any endogenous gene sequence of human or mammalian cell-lines. Horizon offers in excess of 16,500 products, almost all of which are based on the application of gene editing to generate cell lines that accurately model the disease-causing mutations found in genetically based diseases. These 'patients-in-a-test-tube' are being used by customers to identify the effect of individual or compound genetic mutations on drug activity, patient responsiveness and resistance, which may lead to the successful prediction of which patient sub-groups will respond to currently available and future drug treatments.

Horizon Discovery

Entering the post-genomic era: Translating genetic information into personalized medicine



Horizon’s Goals

Horizon aspires to provide science-driven research solutions that:

  • Provide powerful research tools to advance the development of personalized medicines, unlocking the promise of the human genome project for the benefit of scientific researchers, patients and society
  • Enable more efficient and cost-effective manufacture of biological drugs through development of optimized bioprocessing cell lines
  • Support improved healthcare outcomes for patients and better economic outcomes for drug developers and healthcare payers through our partners
  • Provide molecular reference standards that enable the implementation of error-free companion diagnostic regimens so that the right drug is administered to the right patient

Our Products